If they have a story to sell the sp won’t go much lower. Why...

If they have a story to sell the sp won’t go much lower. Why would they rely on govt grants to keep afloat at this time that production is in progress? The grant should just serve as additional cash buffer, should have raised money when it was 3o cents and create a narrative that resonates with shareholders, such as $20m is being raised now as we ramp up production upon validation of these initial launch at these labs. I’m pretty sure holders will be supportive if there is a good vision. If they fail big time, it’s okay at least they’re trying to really push it to fruition, then just sell and the holders will share in the carcass, rather than a waiting game of years and death with a thousand cuts. This is moving without much interest atm. After the Europe or US trade conferences were there no interest? Such that we’re entire relying on st Vincent to create a commercialisation case study? Really? Multi billion dollar target market and no interest in US and Europe? Even with fda and the S eci? Just brainstorming you folks in case you have some insights to give this thread a kick that makes new parties interested and benefit from the potential. No one seems questioning the potential but how do we get there? Management of change or Change the management etc

...back to my cave